WFDC2 and ovarian carcinoma: Several large-sample clinical studies have shown that HE4 has higher sensitivity and specificity than CA125 as a marker for ovarian cancer lesions (31), and greater sensitivity in the postoperative monitoring of ovarian cancer patients.